论文部分内容阅读
复治性肺结核患者具有病程长,病变范围广,多有耐药性等特点。我们将链霉素,对氨基水杨酸钠(PAS)静脉滴注,联合其他抗痨药物用于13例复治性肺结核的治疗,取得了良好的效果,报道如下。 1 临床资料 1.1 病例选择 1996年6月至1997年12月收治复治性肺结核患者13例,其中男8例,女5例,年龄30～65岁,平均年龄46.5岁。浸润性肺结核9例,肺结核并发结核性胸膜炎3例,慢性纤维空洞型肺结核1例。13例患者有肺结核病史5～14年,均经过化疗临床症状消失后多次复发,胸片示渗出性病灶者,全部病例痰菌涂片阳性。
Patients with re-treatment of pulmonary tuberculosis have a longer duration, a wide range of lesions, multi-drug resistance and so on. We have streptomycin, sodium p-aminosalicylate (PAS) intravenous infusion, combined with other anti-tuberculosis drugs for the treatment of 13 cases of re-treatment of tuberculosis, and achieved good results reported below. 1 Clinical data 1.1 Case Selection In June 1996 to December 1997, 13 patients received re-treatment of pulmonary tuberculosis, including 8 males and 5 females, aged 30 to 65 years, with an average age of 46.5 years. Invasive pulmonary tuberculosis in 9 cases, tuberculosis complicated by tuberculous pleurisy in 3 cases, 1 case of chronic fibrous hollow tuberculosis. Thirteen patients had a history of pulmonary tuberculosis for 5 to 14 years. All of them had repeatedly relapsed after the clinical symptoms of chemotherapy disappeared. The chest X-ray showed exudative lesions and the sputum smear was positive in all cases.